PRRT2 and prostate carcinoma: In addition, binding of TPA to PKC activates PKC and its binding to RACK1, which in turn triggers translocation of RACK1 from the nucleus to the cytoplasm, inactivation of MCM7, and disintegration of the DNA replication initiation complex in prostate cancer [41].